Stopping the VTE Epidemic: An Innovative, Cutting Edge, and State-of-the-Art Action Plan

Sponsored by the North American Thrombosis Forum and Lankenau Medical Center

This free symposium offers attendees insight into the most recent medical research and innovation in the field of venous thromboembolism.  This program, taught by key opinion leaders, will focus on helping our most vulnerable patients.

This program will drill down on detailed strategies to protect hospitalized patients from PE, DVT, and stroke.  The program will address the critical role of the hospitalist and other providers who care for hospitalized medically ill patients in developing protocols to maximize the quality of care of VTE patients, the do’s and don’ts of transitioning care from the hospital to the home, and the management of bleeding complications from non-warfarin anticoagulants.

At the conclusion of this program, attendees will be able to:

  • Have the knowledge and tools to improve the lack of awareness around the critical unmet need in VTE prophylaxis and treatment at their institution.
  • Implement successful transitions of care from hospital to discharge to post discharge prophylaxis that ensure protection of vulnerable medically ill patients
  • Understand the management of NOACs and reversibility in the unlikely event of bleeding.

This event is part of NATF’s “Avoiding the Avoidable: Pathways for VTE Prevention in the Vulnerable Medically Ill” program series.



This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of ScientiaCME, Main Line Health System, and NATF. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.

ScientiaCME designates this educational activity for a maximum of 2.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners (NPs): The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s) TM from organizations accredited by the ACCME.  ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)TM

Physician Assistants: The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. 

Nurses: may claim credit for activities approved for AMA PRA Category 1 Credit(s)™ in most states for up to 50% of the nursing requirement for recertification. 

Medical Practice Executives: The American College of Medical Practice Executives accepts AMA PRA Category 1 Credit(s) TM from organizations accredited by ACCME.


ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 2.00 hours (0.20 CEUs) of continuing education.  Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test.   Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.  ACPE # 0574-9999-18-002-L01-P.

This course is not valid for CE credit after May 19, 2018 . Successful completion of the post-test and completion of the program evaluation is required to obtain a CME certificate.

Additional details for this past event are no longer available.